FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080034 [Registered on: 07/02/2025] Trial Registered Prospectively
Last Modified On: 06/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   The Role of Manasika Bhavas in etiopathogenesis of Raktachap and its management with Pushkar muladi churna 
Scientific Title of Study   The Role of Manasika Bhavas in etiopathogenesis of Uccharaktachapa (Essential Hypertension) and its management with Pushkar muladi churna and Shirodhara 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mohd Irfan Ahmad Quraishi 
Designation  P G Scholar 
Affiliation  S G M P G Ayurvedic college and hospital Saheri Ghazipur 
Address  Department of Rog Nidana, S G M P G Ayurvedic college and hospital Saheri

Ghazipur
UTTAR PRADESH
233302
India 
Phone  9621569518  
Fax    
Email  dr.Irfan831@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sharad Kumar Gawali 
Designation  Professor 
Affiliation  S G M P G Ayurvedic college and hospital Saheri Ghazipur 
Address  Head of Department Rog Nidana, S G M P G Ayurvedic college and hospital Saheri

Ghazipur
UTTAR PRADESH
233302
India 
Phone  9621569518  
Fax    
Email  drshyamlal80@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mohd Irfan Ahmad Quraishi 
Designation  P G Scholar 
Affiliation  S G M P G Ayurvedic college and hospital Saheri Ghazipur 
Address  Department Of Rog Nidana, S G M P G Ayurvedic college and hospital Saheri

Ghazipur
UTTAR PRADESH
233302
India 
Phone  9621569518  
Fax    
Email  dr.Irfan831@gmail.com  
 
Source of Monetary or Material Support  
Department of Rog nidana S G M P G Ayurvedic College and Hospital Saheri Ghazipur Uttar pradesh India 233302 
 
Primary Sponsor  
Name  Dr Mohd Irfan Ahmad Quraishi 
Address  S G M P G Ayurvedic college and hospital Saheri Ghazipur, Uttar Pradesh India 233302 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mohd Irfan Ahmad Quraishi   S. G. M. P. G. Ayurvedic College and Hospital  Department of Rog Nidana Saheri India 233302
Ghazipur
UTTAR PRADESH 
9621569518

dr.Irfan831@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC S.G.M.P.G. Ayurvedic College Saheri Ghazipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:I10||Essential (primary) hypertension. Ayurveda Condition: RAKTAVRUTAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: pushkarmuladi churna, Reference: BR, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 1 Months, anupAna/sahapAna: Yes(details: -), Additional Information: -
2Comparator ArmProcedure-KSHIRDHARA (Procedure Reference: BR, Procedure details: Kshiradhara will be performed for 45 minutes for the duration of 21 days to all the patients with proper Purva and Pashchat karma of Shirodhara )
(1) Medicine Name: Pushkarmuladi churna, Reference: BR, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Duration: 2 Months
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Criteria for the selection of the patients will be chiefly based on the criteria suggested
2. Known cases of hypertension.
3. Patients between the age 20-70 years
4. Willing to participate in the study and informed consent
 
 
ExclusionCriteria 
Details  • Patients suffering from hypertension along with I.H.D., C.H.D., C.A.D., coarctation of aorta
• Renal failure
• Endocrine diseases
• Hypertension with cerebral complications e.g. hypertensive encephalopathy, cerebral haemorrhage, convulsive seizure
• Malignant hypertension etc.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Routine haematological investigation such as Hb TC DC ESR .
2. Biochemical tests like blood urea serum creatinine serum cholesterol triglyceride HDL and fasting blood sugar and post prandial blood sugar.
3. Microscopic and routine examination of urine
4. Microscopic and routine examination of stool.
5. ECG and X-ray chest wherever required.
 
4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
For the assessment of the therapy, The following scoring pattern will be followed.  1 MONTH 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   18/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The whole research work will be summarized and conclusion will be made on the basis of the observation which will be done on the subjective and objective parameters. Result will be analyzed statically & discussed accordingly 
Close